Lv55
1220 积分 2021-02-19 加入
HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety Profiles
3天前
已完结
Guanylyl Cyclase Receptors
8天前
已完结
Guanylyl Cyclases and Signaling by Cyclic GMP
8天前
已关闭
664TiP BEHOLD-2: A phase I/II randomised study evaluating GSK5733584, a B7-H4-targeted antibody-drug conjugate, in combination with anti-cancer agents in patients with advanced solid tumours
14天前
已关闭
Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects
14天前
已完结
Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer
14天前
已完结
How to Design Next-generation of Antibody-Drug Conjugates for Cancer Treatment: Lessons from Unsuccessful Clinical Trials
1个月前
已完结
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
1个月前
已完结
抗CD20单克隆抗体治疗非霍奇金淋巴瘤的研究进展
2个月前
已完结
皖公网安备34019202002308
